Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 05, 2015 11:20 AM ET

Biotechnology

Company Overview of OncoMed Pharmaceuticals, Inc.

Executive Profile

Laurence A. Lasky Ph.D.

Director and Member of Nominating & Corporate Governance Committee, OncoMed Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 11 different industries.

See Board Relationships
64$286,293

Background

Dr. Laurence A. Lasky, also known as Larry, Ph.D., was a Partner of U.S. Venture Partners. Dr. Lasky was a Venture Partner at U.S. Venture Partners. He was responsible for investing in healthcare technologies, specifically focusing on financing and creating world class biopharmaceutical companies the discovery, development, and commercialization of new therapies to treat major unmet medical needs and biotechnology companies providing goods and services to this industry. ...

Corporate Headquarters

800 Chesapeake Drive
Redwood City, California 94063

United States

Phone: 650-995-8200
Fax: 650-995-8600

Board Members Memberships

Former Director
Trustee
Former Director
Director
Former Director
Director
Former Director
Director
Director
2004-Present
Director and Member of Nominating & Corporate Governance Committee

Education

PhD 1978
University of California-Los Angeles
BA 1973
University of California-Los Angeles
Post-Doctoral Training 1981
University of California-Los Angeles

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$37,665
Total Calculated Compensation$286,293
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OncoMed Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.